RCAG
NTUS

Rehmann Capital Advisory Group’s Natus Medical Inc NTUS Stock Holding History

Rehmann Capital Advisory Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-21
Closed -$725 – 2203
2018
Q2 		$725 Buy
+21
New +$736 ﹤0.01% 2026

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Rehmann Capital Advisory Group's NTUS Position: Q3 2018 in Review

Rehmann Capital Advisory Group sold out of Natus Medical Inc (NTUS) in Q3 2018, closing a stake of 21 shares — an estimated $725 sold.

Rehmann Capital Advisory Group first reported a position in NTUS in Q2 2018 and held it in 1 quarter. The position peaked at $725 in Q2 2018. 176 funds tracked by Wall St. Rank hold NTUS as of Q3 2018.

  • Rehmann Capital Advisory Group reported no remaining Natus Medical Inc position as of Q3 2018 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 21 Natus Medical Inc shares in Q3 2018, an estimated $725.
  • Rehmann Capital Advisory Group first reported a position in Natus Medical Inc in Q2 2018 and held it in 1 quarter.
  • Rehmann Capital Advisory Group's Natus Medical Inc position peaked at $725 in Q2 2018.
  • 176 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2018.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2018, filed 20 Nov 2018.